Oncocyte secures $29.1 million to advance FDA assay
IRVINE, Calif. - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, has announced a funding round led by ...
News Medical on MSN3d
Blood test for Alzheimer’s could replace costly and invasive spinal taps
Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...
TCTMD12d
GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke
Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...
Hologic announces FDA clearance of Aptima SARS-CoV-2 assay
Hologic (HOLX) announced that the FDA has granted 510(k) clearance for the company’s Aptima SARS-CoV-2 assay, which was first granted Emergency ...
Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay
PLA codes like 0249U are essential building blocks for new diagnostics, as they solidify assay recognition within payers’ billing systems and often represent a significant step in test validation.
HealthDay on MSN3d
IgG-Guided Elimination Diet Beneficial for Irritable Bowel Syndrome
Patients with irritable bowel syndrome (IBS) on an immunoglobulin (Ig)G-guided elimination diet are more likely to h ...
Medical Xpress on MSN13d
AI-powered sensor for high-sensitivity cardiac diagnostics could democratize access
A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...
clubofmozambique.com13d
Altona Rare Earths announces promising fluorspar assay results at Monte Muambe, Mozambique
Altona reports assay results with 88.03% CaF2 from Monte Muambe. Company advances studies for efficient fluorspar production.